Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
D000818:Animals; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003864:Depression, Chemical; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008744:Methylamines / Q000008:administration & dosage / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D008938:Mitosis / Q000187:drug effects; D014747:Vinblastine / Q000627:therapeutic use
D004273:DNA, Neoplasm; D004338:Drug Combinations; D008744:Methylamines; D003561:Cytarabine; D014747:Vinblastine; D003078:Colchicine